
ALT FDA Drug Approval graphic with text reading "FDA Approves First Drug to Treat Adults with Primary Membranous Nephropathy." The navy blue square graphic includes the FDA logo in the upper right corner, a gold "Drug Approval" banner in the upper left, and icons of medication bottles, capsules, and a syringe along the bottom.

ALT A graph from the Original Article "Discontinuing Statins in Older Adults without Cardiovascular Disease." The trial name, STREAM, is in parentheses after the title. The graph shows estimated cumulative incidence of primary-outcome events. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.

ALT A bar graph titled "Systolic Blood Pressure." The y-axis shows mean pressure in mm Hg from 70 to 170. The x-axis has two sections: "Prestudy" with values 1 and 2, and "Post-Treatment" with 6 months, 1 year, and 2 years. Bars represent mean pressure with sample size noted: 9 and 14 for Prestudy, and 8, 8, and 11 for Post-Treatment. Error bars are included.







































